Patients with hidradenitis suppurativa (HS) in Canada often wait long periods of time to receive an HS diagnosis and receive evidence-based therapy, highlighting the need for increased ...

HS severely impacts QOL, with delayed diagnosis worsening disease severity and outcomes, necessitating early intervention and improved care access. Pain, emotional distress, and socioeconomic ...

Treatment for hidradenitis suppurativa (HS) varies depending on the condition’s severity. Early HS can be manageable with medication, while more severe cases may require both medication and surgery.

Maybe it’s that new exercise program you’ve been following. Or maybe you just sweat a lot. Whatever the reason, you’ve noticed a bunch of red bumps on your skin lately, especially in the folds of your ...

Jul. 17, 2025 -- What is hidradenitis suppurativa (HS)? Why is it often misdiagnosed, and what does effective care look like? We spoke to Jennifer L. Hsiao, MD, dermatologist and director of the ...

Getting a diagnosis of hidradenitis suppurativa (HS) can be overwhelming, especially if you’ve never heard of the condition before—and so many people have not, even though HS is not actually rare (it ...

Many people live for years with hidradenitis suppurativa before getting an accurate diagnosis, sometimes believing that they have acne (pimples). But HS is not acne, and it can get worse without ...

The DPP1 inhibitor did not beat placebo in this trial, leaving branded Bimzelx and Cosentyx, as well as Humira and its generics to reign across the HS market.

At least five factors influence treatment selection among patients with hidradenitis suppurativa (HS). The median age of the participants was 38.5 years, 76% were female, and 71% were Black; 95% had ...

Hidradenitis suppurativa (HS) is a chronic (long-term) condition that causes painful lesions under the skin. Many people take years to receive a proper HS diagnosis because it can look like pimples or ...

Hidradenitis suppurativa (HS) is a chronic skin condition that affects the sweat glands and hair follicles. Stage 1 is the mildest form of the condition. HS, or acne inversa, commonly appears where ...

Swiss biotech firm, MoonLake Immunotherapeutics, saw its shares double after encouraging Phase 2 results for sonelokimab, a Nanobody therapy for inflammatory diseases. The MIRA trial revealed ...